Good afternoon, everyone, and thank you for joining us today. 2025 was a year of exceptional execution, one that proved the ...
Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results